This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
HealthdirectFree Australian health advice you can count on.
INN: tobramycin
Data updated: 2026-04-25
Available in:
🇨🇿🇩🇪🇬🇧🇷🇺🇸🇰
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Viatris Healthcare Limited
ATC Code
J01GB01
Source
EMA · EMEA/H/C/002155
(
ARTG
)
TOBI is indicated for the management of cystic fibrosis patients with P.aeruginosa infections. Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with FEV,<25% or >75% predicted, or patients colonised with Burkolderia cepacia (see CLINICAL TRIALS).
⚠️ Warnings
• Caution should be exercised in patients with history of myasthenia gravis, Parkinson disease, hearing, nerve or kidney problems, burns, dehydration, low blood minerals, any allergy, who are taking other medications, elderly, children, during pregnancy and breastfeeding.
• It may lead to dehydration, drink adequate fluid.
• Avoid long-term use of this medication; otherwise it will cause secondary infection.
• Take full course of treatment and avoid excess dosage.
• Monitor kidney function, hearing tests, blood electrolyte levels regularly while taking this medication.